OnVagus, Inc. is a biotechnology startup founded in 2022 with the goal of improving the quality of life and survival of cancer patients who develop cachexia.

Our novel, non-invasive approach keeps patients fighting longer and harder while feeling better. At OnVagus, Inc., we harness the power of the gut-brain axis to prevent and reverse cachexia, all with no pills, no needles, and no surgery. This novel device reverses key clinical features of cachexia, including weight loss, muscle atrophy, anorexia, and inflammation, to give patients their best shot at beating cancer and a more comfortable experience during the process.